KINNOV THERAPEUTICS
🇫🇷France
A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine
Phase 1
Completed
- Conditions
- Alcohol Use Disorder
- Interventions
- First Posted Date
- 2023-11-27
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Kinnov Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT06147622
- Locations
- 🇫🇷
Eurofins Optimed, Gières, France
Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Kinnov Therapeutics
- Target Recruit Count
- 154
- Registration Number
- NCT04108104
- Locations
- 🇫🇷
Association Hospitalière de Bourgogne Franche-Comté, Saint-Rémy, France
🇫🇷Cabinet Médical, Bersée, France
🇫🇷HIA Clermont Tonnerre, Brest, France
© Copyright 2025. All Rights Reserved by MedPath